313 related articles for article (PubMed ID: 9093706)
1. Late relapse of germ cell tumors after cisplatin-based chemotherapy.
Gerl A; Clemm C; Schmeller N; Hentrich M; Lamerz R; Wilmanns W
Ann Oncol; 1997 Jan; 8(1):41-7. PubMed ID: 9093706
[TBL] [Abstract][Full Text] [Related]
2. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.
Amato RJ; Ro JY; Ayala AG; Swanson DA
Urology; 2004 Jan; 63(1):144-8; discussion 148-9. PubMed ID: 14751368
[TBL] [Abstract][Full Text] [Related]
3. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
4. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
[TBL] [Abstract][Full Text] [Related]
5. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].
Fléchon A; Biron P; Philip I; Blay JY; Droz JP
Bull Cancer; 1999 Apr; 86(4):391-9. PubMed ID: 10341344
[TBL] [Abstract][Full Text] [Related]
6. Late relapse of testicular cancer.
Baniel J; Foster RS; Gonin R; Messemer JE; Donohue JP; Einhorn LH
J Clin Oncol; 1995 May; 13(5):1170-6. PubMed ID: 7537800
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
8. Late relapse in testicular germ cell tumors.
Detti B; Livi L; Scoccianti S; Meattini I; Gacci M; Lapini A; Biti G
Tumori; 2007; 93(5):428-31. PubMed ID: 18038873
[TBL] [Abstract][Full Text] [Related]
9. Isolated central nervous system relapse of non-seminomatous germ cell tumour of the testis. A case report and review of the literature.
Cohn DA; Stuart-Harris R
Oncology; 2001; 61(3):184-8. PubMed ID: 11574772
[TBL] [Abstract][Full Text] [Related]
10. Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors.
Motzer RJ; Sheinfeld J; Mazumdar M; Bajorin DF; Bosl GJ; Herr H; Lyn P; Vlamis V
J Clin Oncol; 1995 Nov; 13(11):2700-4. PubMed ID: 7595727
[TBL] [Abstract][Full Text] [Related]
11. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
[TBL] [Abstract][Full Text] [Related]
12. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
13. Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy.
Ronnen EA; Kondagunta GV; Bacik J; Marion S; Bajorin DF; Sheinfeld J; Bosl GJ; Motzer RJ
J Clin Oncol; 2005 Oct; 23(28):6999-7004. PubMed ID: 16192587
[TBL] [Abstract][Full Text] [Related]
14. [A case of testicular cancer in which complete response was achieved with chemotherapy including cisplatin, etoposide and bleomycin, and salvage surgery].
Uekado Y; Matsumoto M; Inagaki T; Shintani Y
Gan To Kagaku Ryoho; 1994 Mar; 21(4):543-6. PubMed ID: 7510465
[TBL] [Abstract][Full Text] [Related]
15. [Management of stage I testicular nonseminomatous germ cell tumors with an embryonic carcinomatous component. 18 cases].
Drianno N; Robert M; Legouffe E; Guiter J; Navratil H
Prog Urol; 1997 Sep; 7(4):622-7. PubMed ID: 9410322
[TBL] [Abstract][Full Text] [Related]
16. Improved prognosis of patients with intermediate- and poor-risk nonseminomatous germ cell tumours by optimizing combined treatment.
Pentheroudakis G; De Bono JS; Kaye SB; Simpson A; Paul J; Brown I; Pamenter B; Kirk A; Vasey P; Raby N; Kirk D
BJU Int; 2003 Jul; 92(1):36-42. PubMed ID: 12823380
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of Anglian Germ Cell Cancer Group surveillance versus patients with Stage 1 nonseminoma treated with adjuvant chemotherapy.
Oliver RT; Ong J; Shamash J; Ravi R; Nagund V; Harper P; Ostrowski MJ; Sizer B; Levay J; Robinson A; Neal DE; Williams M;
Urology; 2004 Mar; 63(3):556-61. PubMed ID: 15028457
[TBL] [Abstract][Full Text] [Related]
18. Extragonadal germ cell tumor: a clinical study.
Bassetto MA; Pasini F; Franceschi T; Mustacchi G; Cetto GL
Anticancer Res; 1995; 15(6B):2751-4. PubMed ID: 8669858
[TBL] [Abstract][Full Text] [Related]
19. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancer.
Studer UE; Fey MF; Calderoni A; Kraft R; Mazzucchelli L; Sonntag RW
Eur Urol; 1993; 23(4):444-9. PubMed ID: 7687549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
